Effects of peptide therapy on ex vivo T-cell responses
Open Access
- 30 April 1998
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 101 (4), 506-513
- https://doi.org/10.1016/s0091-6749(98)70358-6
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-γ production in CD4+ T cellsJournal of Allergy and Clinical Immunology, 1997
- Differential efficacy of lymphocyte- and monocyte-selective pretreatment with a type 4 phosphodiesterase inhibitor on antigen-driven proliferation and cytokine gene expressionJournal of Allergy and Clinical Immunology, 1997
- Update on cytokinesJournal of Allergy and Clinical Immunology, 1996
- Blocked Ras Activation in Anergic CD4 + T CellsScience, 1996
- Modern concepts of immunotherapyCurrent Opinion in Immunology, 1993
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaThe New England Journal of Medicine, 1992
- Double-blind placebo-controlled immunotherapy with mixed grass-pollen allergoids: II. Comparison between parameters assessing the efficacy of immunotherapyJournal of Allergy and Clinical Immunology, 1988
- A comparison of immunotherapy schedules for injection treatment of ragweed pollen hay feverJournal of Allergy and Clinical Immunology, 1982
- Generation of Antigen-Specific Suppressor Cells during Allergy DesensitizationThe New England Journal of Medicine, 1980
- PROPHYLAXIS OF SUMMER HAY-FEVER AND ASTHMA: A CONTROLLED TRIAL COMPARING CRUDE GRASS-POLLEN EXTRACTS WITH THE ISOLATED MAIN PROTEIN COMPONENTThe Lancet, 1954